Discover open access scientific publications

Search, annotate, share and cite publications

Publications by D. H. Shin

Akt/mTOR Counteract the Antitumor Activities of Cixutumumab, an Anti-Insulin-Like Growth Factor I Receptor Monoclonal Antibody

Molecular Cancer Therapeutics
Cancer ResearchOncology
2011English

Formation of Black Ceramic Layer on Aluminum Alloy by Plasma Electrolytic Oxidation in Electrolyte Containing Na2WO4

Materials Transactions
Mechanics of MaterialsMaterials ScienceCondensed Matter PhysicsMechanical Engineering
2012English

Related publications

Molecular Predictors of Response to a Humanized Anti-Insulin-Like Growth Factor-I Receptor Monoclonal Antibody in Breast and Colorectal Cancer

Molecular Cancer Therapeutics
Cancer ResearchOncology
2009English

Antiapoptotic Signalling by the Insulin-Like Growth Factor I Receptor, Phosphatidylinositol 3-Kinase, and Akt.

Molecular and Cellular Biology
Cell BiologyMolecular Biology
1997English

RAV12 Accelerates the Desensitization of Akt/PKB Pathway of Insulin-Like Growth Factor I Receptor Signaling in COLO205

Cancer Research
Cancer ResearchOncology
2007English

R1507, an Anti-Insulin-Like Growth Factor-1 Receptor (IGF-1R) Antibody, and EWS/FLI-1 siRNA in Ewing's Sarcoma: Convergence at the IGF/IGFR/Akt Axis

PLoS ONE
Multidisciplinary
2011English

Insulin-Like Growth Factor-I-Induced DNA Synthesis in Insulin-Secreting Cell Line RINm5F Is Associated With Phosphorylation of the Insulin-Like Growth Factor-I Receptor and the Insulin Receptor Substrate-2

Journal of Endocrinology
EndocrinologyMetabolismDiabetes
1998English

Regulation of Survival Signals From the Insulin-Like Growth Factor-I Receptor

Biochemical Society Transactions
Biochemistry
2000English

Insulin-Like Growth Factor 1 Receptor Antibody Induces Rhabdomyosarcoma Cell Death via a Process Involving AKT and BCL-xL

Oncogene
Cancer ResearchGeneticsMolecular Biology
2010English

The Three Dimensional Structure of the Type I Insulin-Like Growth Factor Receptor

Molecular Pathology
2001English

Phase I Study of the Anti Insulin-Like Growth Factor 1 Receptor (IGF-1R) Monoclonal Antibody, AVE1642, as Single Agent and in Combination With Bortezomib in Patients With Relapsed Multiple Myeloma

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy